April 2026: advisory boards, AACR partnering and two posters
Scientific Advisory Board meeting in Berlin, Clinical Advisory Board meeting and AACR Oncology Industry Partnering Event in San Diego, followed by two posters at AACR 2026.
April 2026 brings a series of meetings in Berlin and San Diego:
- April 13–14, Berlin: Scientific Advisory Board meeting with external R&D experts, to build out the scientific foundation of Tacalyx's glycan-targeted oncology programmes.
- April 16–17, San Diego: CEO Jean Engela takes part in the AACR Oncology Industry Partnering Event, themed "From Cancer Discoveries to Patients".
- April 16–17, San Diego: Clinical Advisory Board meeting with experts in clinical and translational research, preparing the next development stages of the lead ADC and T-cell engager programmes.
- April 21, San Diego: two posters at the AACR Annual Meeting 2026, on TCX-201 (Poster 5631) and TCX-101 (Poster 5584).
